News & Updates

In what has been dubbed as ‘a small but mighty study’ at ASCO 2022, a phase II trial spearheaded by investigators from Memorial Sloan Kettering Cancer Center in New York, US heralded the remarkable efficacy and safety of the monoclonal antibody dostarlimab for the treatment of locally advanced mismatch repair-deficient (dMMR) rectal cancer.

Changes of taste and smell (TSCs), as well as psychological comorbidities, occur frequently in globus patients with no evidence of pathologic acid reflux, reports a study.

Even a single course of antibiotics introduced during the development of the gut fungal microbiota (ie, mycobiota) in infants may alter fungal gut composition, a study from Finland suggests.

Individuals who use low-dose aspirin are at risk of developing gastric and duodenal ulcers, especially those who have only recently initiated therapy, a study has found.

Crohn’s disease (CD) remission, induced by either CD exclusion diet with partial enteral nutrition (CDED+PEN) or by exclusive enteral nutrition (EEN), leads to significant changes in metabolite levels in paediatric patients, according to a new study.

The use of a computer-aided detection (CADe) device helps increase the overall rate of adenoma detection during screening and surveillance colonoscopy, reports a new study. Such benefit was apparent even for experienced endoscopists.

Maintenance therapy with the anti-IL-23p19 antibody mirikizumab boosts clinical benefits in moderate-to-severe ulcerative colitis (UC) in the phase III LUCENT-2 trial, improving bowel urgency that is not only disruptive but likewise embarrassing for patients.